Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors

Conditions:   End Stage Renal Disease;   Hepatitis C Intervention:   Drug: 300mg glecaprevir/pibrentasivir 120mg Sponsor:   Johns Hopkins University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials